SHENZHEN, China, March 21, 2011 /PRNewswire-Asia-FirstCall/ --
Tongjitang Chinese Medicines Company (the "Company" or
"Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical
company focusing on the development, manufacturing, marketing and
selling of modernized traditional Chinese medicine in China, today announced that it plans to
release its fourth quarter and full year 2010 financial results
after the market close on March 25,
2011.
Tongjitang's management team will hold a conference call on
Monday, March 28, 2011, at
8:00 a.m. U.S. Eastern Time
(8:00 p.m. Beijing/Hong
Kong time) following the announcement. Listeners may access
the call by dialing the following numbers:
United States toll free:
|
1-877-941-2321
|
|
Hong Kong toll free:
|
800-908-530
|
|
China toll free:
|
400-1200611
|
|
International:
|
1-480-629-9714
|
|
|
|
Listeners may access the replay from approximately two hours
after the call ends through April 4,
2011 by dialing the following numbers:
United States toll free:
|
1-877-870-5176
|
|
International:
|
1-858-384-5517
|
|
Password:
|
4426889
|
|
|
|
An audio webcast of the call will also be available through the
Company's website at www.tongjitang.com.
About Tongjitang Chinese Medicines Company
Tongjitang Chinese Medicines Company, through its operating
subsidiaries Guizhou Tongjitang Pharmaceutical Co., Ltd., Guizhou
Long-Life Pharmaceutical Company Limited, Qinghai Pulante
Pharmaceutical Co., Ltd. and Anhui Jingfang Pharmaceutical Co.,
Ltd., is a vertically integrated specialty pharmaceutical company
focused on the development, manufacturing, marketing and selling of
modernized traditional Chinese medicine in China. Tongjitang's principal executive
offices are located in Shenzhen,
China.
Tongjitang's flagship product, Xianling Gubao, is the leading
traditional Chinese medicine for the treatment of osteoporosis in
China as measured by sales in
Renminbi. In addition to Xianling Gubao, the Company
manufactures and markets 35 other modernized traditional Chinese
medicine products and 36 western medicines. Please visit
www.tongjitang.com for more information.
CONTACT
|
|
|
|
ICR, LLC
|
|
Ashley M. Ammon
|
|
203-682-8200 (Investor
Relations)
|
|
|
SOURCE Tongjitang Chinese Medicines Company